Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 8,679 calls trading, 1.1x expected, and implied vol increasing almost 7 points to 118.97%. Jan-25 7.5 calls and 12/6 weekly 7.5 calls are the most active options, with total volume in those strikes near 1,700 contracts. The Put/Call Ratio is 0.13. Earnings are expected on February 27th.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Recursion Pharmaceuticals’ (RXRX) Bold Acquisition Places it as an Industry Leader
- Recursion announces first patient dosed in Phase 1/2 trial of REC-1245
- Unusually active option classes on open December 2nd
- Cathie Wood’s ARK Investment buys 383K shares of Recursion Pharmaceuticals today
- Unusually active option classes on open November 20th